MedPath

BYLIUM LIQ

BYLIUM LIQ

Discontinued
DIN Number

00378607

Drug Class

Human

Market Date

Dec 31, 1977

Company
HC

superco enr.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00378607
AIG Number0510186004
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB57 CASCARA, COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

BOLDOActive
Strength: 176 MG / 10 ML
Monograph: BOLDO
CASCARA SAGRADAActive
Strength: .35 ML / 10 ML
Monograph: CASCARA SAGRADA
MAGNESIUM SULFATEActive
Strength: 1.521 G / 10 ML
Monograph: MAGNESIUM SULFATE
PANCREATINActive
Strength: 176 MG / 10 ML
Monograph: PANCREATIN
PEPTONEActive
Strength: 176 MG / 10 ML
Monograph: PEPTONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.